Results(4626)
Human genetics of myocarditis: overall, after mRNA COVID-19 vaccination, and after SARS-CoV-2 infection
United States
EU PAS number:
EUPAS1000000728
First published:
10/04/2026
Study
Ongoing
The Use of Oral Fluoroquinolones in Canada: Drug Utilization Study Update
Canada
EU PAS number:
EUPAS107333
First published:
10/04/2026
Study
Finalised
Observational study to investigate safety and effectiveness of lorlatinib as first line treatment for ALK-gene rearranged unresectable advanced/recurrent NSCLC patients in Japan clinical setting
Japan
EU PAS number:
EUPAS1000000117
First published:
09/04/2026
Study
Ongoing
CAB LA PrEP Cohort: Prospective Cohort Study to Assess Adherence and Effectiveness of, and Monitor for Hepatotoxicity and Resistance to, Cabotegravir for Pre-Exposure Prophylaxis in Europe (221935)
Belgium
France
Ireland
Italy
Spain
United Kingdom
EU PAS number:
EUPAS1000000299
First published:
09/04/2026
Study
Planned
A Post-Marketing Safety Study to Evaluate the Safety of VELSIPITY® (Etrasimod) Exposure During Pregnancy (C5041043)
Canada
United States
EU PAS number:
EUPAS1000000672
First published:
09/04/2026
Study
Planned
Real World Use, Effectiveness and Safety of Romosozumab among Osteoporosis Patients in Guangdong China (20250009)
China
EU PAS number:
EUPAS1000000758
First published:
09/04/2026
Study
Planned
Observational Pregnancy Safety Study of Women Exposed to Nifurtimox During Pregnancy to Describe the Risk of Pregnancy and Maternal Complications and Other Events of Interest on the Developing Fetus, Neonate, and Infant
Argentina
Bolivia, Plurinational State of
Chile
El Salvador
Germany
Guatemala
Honduras
Mexico
Spain
United States
Uruguay
EU PAS number:
EUPAS1000000884
First published:
09/04/2026
Study
Planned
DARWIN EU® - Neonatal seizures: Incidence, prevalence, patient characterisation, and treatments in European countries
Finland
France
Hungary
Norway
EU PAS number:
EUPAS1000000822
First published:
09/04/2026
Study
Ongoing
Enzalutamide and Other Androgen Receptor Pathway Inhibitors (ARPIs) in Metastatic Hormone Sensitive Prostate Cancer (mHSPC): A Non-Interventional Center-based Chart Review in Europe (ENHANCE)
France
Germany
EU PAS number:
EUPAS1000000776
First published:
09/04/2026
Study
Ongoing
Bimekizumab Pregnancy Exposure and Outcome Registry: An OTIS Autoimmune Diseases in Pregnancy Study
Canada
United States
EU PAS number:
EUPAS1000000968
First published:
09/04/2026
Study
Ongoing
Real-world experience of children with growth hormone deficiency who switched from daily growth hormone to the Long-Acting Growth Hormone Somatrogon
Czechia
Israel
EU PAS number:
EUPAS1000000829
First published:
09/04/2026
Study
Ongoing
Assessing the impact of remission at 12-months post-initiation of biologic therapy on long-term clinical outcomes of patients with severe asthma (SPOTLIGHT)
Argentina
Belgium
Brazil
Bulgaria
Canada
Colombia
Denmark
Estonia
Greece
India
Ireland
Italy
Japan
Korea, Republic of
Kuwait
Mexico
Norway
Poland
Portugal
Saudi Arabia
Singapore
Spain
Taiwan
United Arab Emirates
United Kingdom
United States
EU PAS number:
EUPAS1000000789
First published:
09/04/2026
Study
Finalised
A Non-Interventional Study (NIS) PASS to characterize secondary malignancies of T-cell origin following tisagenlecleucel therapy (CCTL019B2402)
Australia
Austria
Brazil
Canada
Czechia
France
Germany
Hong Kong
Israel
Italy
Japan
Korea, Republic of
Netherlands
Poland
Russian Federation
Saudi Arabia
Singapore
Spain
Switzerland
Taiwan
United Kingdom
United States
EU PAS number:
EUPAS1000000749
First published:
08/04/2026
Study
Ongoing
A regulatory requirement non-interventional study to monitor the safety and effectiveness of Spesolimab in Korean patients with flares with generalized pustular psoriasis
Korea, Republic of
EU PAS number:
EUPAS1000000278
First published:
08/04/2026
Study
Discontinued
Real-world Persistency, Effectiveness, and Safety Among Patients with NMOSD Treated with Inebilizumab (20250110)
United States
EU PAS number:
EUPAS1000000958
First published:
08/04/2026
Study
Ongoing
An Observational Registry-Based Study to Evaluate the Long-Term Safety of Tofersen in People With SOD1-ALS
United States
EU PAS number:
EUPAS1000000365
First published:
08/04/2026
Study
Ongoing
Post-marketing Safety Study of mRNA-1283 in the United States
United States
EU PAS number:
EUPAS1000000971
First published:
08/04/2026
Study
Planned
A retrospective observational chart review study to evaluate the clinical effectiveness of treatment with zanamivir 10 mg/ml solution for infusion in a cohort of intensive care unit-treated (ICU) patients with complicated influenza infection (208165)
Netherlands
United Kingdom
EU PAS number:
EUPAS37605
First published:
08/04/2026
Study
Ongoing
DARWIN EU® - Assessing the potential association between venlafaxine and heart failure in adults
Denmark
Finland
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000974
First published:
08/04/2026
Study
Ongoing
DARWIN EU® - Feasibility of studies on early (pre-symptomatic) stages of type 1 diabetes mellitus in the DARWIN EU® network
Denmark
Finland
France
Hungary
Netherlands
Spain
EU PAS number:
EUPAS1000000756
First published:
08/04/2026
Study
Finalised
DARWIN EU® - Population demographics and disease frequency across the DARWIN EU® network
Belgium
Croatia
Estonia
France
Germany
Greece
Hungary
Netherlands
Norway
Portugal
Spain
Sweden
United Kingdom
EU PAS number:
EUPAS1000000962
First published:
08/04/2026
Study
Ongoing
Danny Platform
First published:
08/04/2026
Bulgaria
Croatia
Poland
Romania
Serbia
Slovenia
Spain
Data source
Human
Death registry
Drug registry
Hospital inpatient records
Other
Pharmacy dispensing records
Primary care medical recordsRecord completeness: 91%
INFARMED – National Authority of Medicines and Health Products, I.P.
Portugal
First published:
08/04/2026
Institution
EEA National Competent authority
Healthcare payer
Regulatory Authority
ENCePP partner
CROSSROADS-2: Clinical Characteristics, Treatment Patterns, and Treatment Outcomes Among Users of Tezspire: An Electronic Medical Record (EMR) study (20220066)
United States
EU PAS number:
EUPAS1000000053
First published:
08/04/2026
Study
Ongoing
Periodic Knowledge, Attitudes, and Behavior (KAB) Survey of Certified Prescribers to Assess Understanding of the Risks with the BKEMV™ Risk Evaluation and Mitigation Strategy (REMS) (20240216)
United States
EU PAS number:
EUPAS1000000367
First published:
08/04/2026
Study
Ongoing
Evaluating the benefits of RSV maternal vaccination using a Scottish National Dataset. (BORLAND)
United Kingdom
EU PAS number:
EUPAS1000000706
First published:
08/04/2026
Study
Planned
General Use-results Survey of IMDELLTRA in Patients with Small Cell Lung Cancer Progressed after Cancer Chemotherapy (20230313)
Japan
EU PAS number:
EUPAS1000000817
First published:
08/04/2026
Study
Ongoing
Investigating the effect of the 13-valent pneumococcal conjugate vaccine on major adverse cardiovascular events among Medicare enrollees aged ≥65 years in the United States
United States
EU PAS number:
EUPAS1000000520
First published:
08/04/2026
Study
Ongoing
COPD, Bronchiectasis and Asthma Longitudinal Trends
France
Germany
Japan
United States
EU PAS number:
EUPAS1000000925
First published:
08/04/2026
Study
Planned
Real-world Comparative Effectiveness of Evolocumab Versus Ezetimibe in Reducing the Risk of Fatal and Nonfatal Myocardial Infarction (20240027)
United States
EU PAS number:
EUPAS1000000522
First published:
07/04/2026
Study
Ongoing
MS700568_0151: An observational, multicenter, prospective, phase IV study evaluating cladribine tablets’ effects on PROs and their correlation with clinical and biometric parameters using Health Technology in subjects with highly-active RMS at their first switch (CLADFIT-MS)
Italy
EU PAS number:
EUPAS43893
First published:
01/04/2026
Study
Finalised
Frequency of HIV diagnoses among people using oral and LA PrEP (223555)
United States
EU PAS number:
EUPAS1000000371
First published:
01/04/2026
Study
Ongoing
MS100070_0031: Non-interventional cohort registry study to assess characteristics and management of patients with Merkel Cell Carcinoma in Germany (MCC-TRIM)
Germany
EU PAS number:
EUPAS25338
First published:
01/04/2026
Study
Finalised
Fezolinetant Experience for the Treatment of Vasomotor Symptoms Associated with Menopause Among Women in a German Real-life Setting
Germany
EU PAS number:
EUPAS1000000132
First published:
01/04/2026
Study
Ongoing
Prospective Observational Non-interventional Study to Describe Characteristics and Management of Patients With Giant Cell Tumor of Bone Treated With XGEVA and Its Use in Routine Clinical Practice in France (20150360)
France
EU PAS number:
EUPAS21542
First published:
01/04/2026
Study
Finalised
Interim Analysis of Myocarditis and Pericarditis Associated with COMIRNATY in Persons Less Than 21 Years of Age
Canada
United States
EU PAS number:
EUPAS1000000600
First published:
01/04/2026
Study
Cancelled
A multicentre, non-interventional, cohort analysis describing the patients’ experience focusing on safety events among metastatic hormone-sensitive prostate cancer patients treated with Androgen Receptor Pathway Inhibitors (ARPIs) followed through a Telemonitoring tool funded by the French national healthcare insurance complemented with a chart review (ESPERANTO)
France
EU PAS number:
EUPAS1000000759
First published:
01/04/2026
Study
Ongoing
Optimum Patient Care Research Database
First published:
31/03/2026
United Kingdom
United Kingdom (Northern Ireland)
Data source
Human
Other
Primary care medical recordsRecord completeness: 100%
Compare data sources